Reduced Opioid Marketing Could Limit Prescribing Information for Physicians-Reply

JAMA Intern Med. 2018 Oct 1;178(10):1426-1427. doi: 10.1001/jamainternmed.2018.4366.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Analgesics, Opioid*
  • Drug Industry
  • Humans
  • Marketing
  • Physicians*
  • Practice Patterns, Physicians'

Substances

  • Analgesics, Opioid